Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CARBONIC-ANHYDRASE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 90 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gelatt, KN; MacKay, EO
      Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs

      VETERINARY OPHTHALMOLOGY
    2. Petounis, A; Mylopoulos, N; Kandarakis, A; Andreanos, D; Dimitrakoulias, N
      Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: A randomized, open-label, multicenter study inGreece

      JOURNAL OF GLAUCOMA
    3. Bernd, AS; Pillunat, LE; Bohm, AG; Schmidt, KG; Richard, G
      Effect of dorzolamide on ocular hemodynamics and visual function in glaucoma

      OPHTHALMOLOGE
    4. Simmons, ST
      Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension

      CLINICAL THERAPEUTICS
    5. Seong, GJ; Lee, SC; Lee, JH; Chu, YK; Hong, YJ
      Comparisons of intraocular-pressure-lowering efficacy and side effects of 2% dorzolamide and 1 % brinzolamide

      OPHTHALMOLOGICA
    6. Takamata, A; Seo, Y; Ogino, T; Tanaka, K; Fujiki, N; Morita, H; Murakami, M
      Effects of pCO(2) on the CSF turnover rate in rats monitored by Gd-DTPA enhanced T-1-weighted magnetic resonance imaging

      JAPANESE JOURNAL OF PHYSIOLOGY
    7. Cawrse, MA; Ward, DA; Hendrix, DVH
      Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    8. Michaud, JE; Friren, B
      Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    9. Ormrod, D; McClellan, K
      Topical dorzolamide 2%/Timolol 0.5% - A review of its use in the treatmentof open-angle glaucoma

      DRUGS & AGING
    10. Lacheretz, F; Barbier, A; Serradeil-Le Gal, C; Elena, PP; Maffrand, JP; Le Fur, G
      Effect of SR121463, a selective non-peptide vasopressin V-2 receptor antagonist, in a rabbit model of ocular hypertension

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    11. Wang, RF; Serle, JB; Gagliuso, DJ; Podos, SM
      Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes

      JOURNAL OF GLAUCOMA
    12. Rainer, G; Menapace, R; Findl, O; Georgopoulos, M; Kiss, B; Heinze, G
      Randomised fellow eye comparison of the effectiveness of dorzolamide and apraclonidine on intraocular pressure following phacoemulsification cataractsurgery

      EYE
    13. Konstas, AGP; Maltezos, A; Bufidis, T; Hudgins, AG; Stewart, WC
      Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma

      EYE
    14. Alzuet, G; Ferrer-Llusar, S; Borras, J; Martinez-Manez, R
      New Cu(II) and Zn(II) complexes of benzolamide with diethylenetriamine: synthesis, spectroscopy and X-ray structures

      POLYHEDRON
    15. Davidson, MG
      Dorzolamide

      COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN
    16. Brubaker, RF; Ingram, CJ; Schoff, EO; Nau, CB
      Comparison of the efficacy of betaxolol-brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjects

      OPHTHALMOLOGY
    17. Barnebey, H; Kwok, SY
      Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting

      CLINICAL THERAPEUTICS
    18. Guomundsdottir, E; Stefansson, E; Bjarnadottir, G; Sigurjonsdottir, JF; Guomundsdottir, G; Masson, M; Loftsson, T
      Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    19. DeSantis, L
      Preclinical overview of brinzolamide

      SURVEY OF OPHTHALMOLOGY
    20. Barnes, GE; Li, B; Dean, T; Chandler, ML
      Increased optic nerve head blood flow after 1 week of twice daily topical brinzolamide treatment in Dutch-belted rabbits

      SURVEY OF OPHTHALMOLOGY
    21. Silver, LH
      Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt (R))

      SURVEY OF OPHTHALMOLOGY
    22. Sall, K
      The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt (R)) as a primary therapy in patients with open-angle glaucoma or ocular hypertension

      SURVEY OF OPHTHALMOLOGY
    23. Stewart, WC; Sharpe, ED; Harbin, TS; Pastor, SA; Day, DG; Holmes, KT; Stewart, JA
      Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    24. Camras, CB; Toris, CB; Tamesis, RR
      Efficacy and adverse effects of medications used in the treatment of glaucoma.

      DRUGS & AGING
    25. Stewart, WC; Hudgins, AC; Pruitt, CA; Sine, C
      Daily cost of newer glaucoma agents

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    26. Bauer, NJC; Motamedi, M; Wicksted, JP; March, WF; Webers, CAB; Hendrikse, F
      Non-invasive assessment of ocular pharmacokinetics using confocal Raman spectroscopy

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    27. Conroy, CW; Maren, TH
      Corneal sequestration and delivery to ciliary process of six topically applied sulfonamides

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    28. Kappil, JC; Bouchard, CS; Savitt, ML; Kopitas, E
      Short-term effect of dorzolamide on corneal thickness in patients with prior intraocular surgery

      ANNALS OF OPHTHALMOLOGY & GLAUCOMA
    29. Loftssona, T; Jarvinen, T
      Cyclodextrins in ophthalmic drug delivery

      ADVANCED DRUG DELIVERY REVIEWS
    30. Schmitz, K; Banditt, P; Motschmann, M; Meyer, FP; Behrens-Baumann, W
      Population pharmacokinetics of 2% topical dorzolamide in the aqueous humorof humans

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    31. Tamaki, Y; Araie, M; Muta, K
      Effect of topical dorzolamide on tissue circulation in the rabbit optic nerve head

      JAPANESE JOURNAL OF OPHTHALMOLOGY
    32. Kooner, KS
      New agents in glaucoma therapy

      INTERNATIONAL OPHTHALMOLOGY CLINICS
    33. Wilner, A; Raymond, K; Pollard, R
      Topiramate and metabolic acidosis

      EPILEPSIA
    34. Schwartzenberg, GWST; Trope, GE
      Anorexia, depression and dementia induced by dorzolamide eyedrops (Trusopt)

      CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
    35. Fiscella, RG; Geller, JL; Gryz, LL; Wilensky, J; Viana, M
      Cost considerations of medical therapy for glaucoma

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    36. Ingram, CJ; Brubaker, RF
      Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    37. Konowal, A; Morrison, JC; Brown, SVL; Cooke, DL; Maguire, LJ; Verdier, DV; Fraunfelder, FT; Dennis, RF; Epstein, RJ
      Irreversible corneal decompensation in patients treated with topical dorzolamide

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    38. Lewis, PR; Phillips, TG; Sassani, JW
      Topical therapies for glaucoma: What family physicians need to know

      AMERICAN FAMILY PHYSICIAN
    39. D'Andrea, A; D'Andrea, D; Ferreri, G
      Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    40. Conroy, CW; Maren, TH
      The ocular distribution of methazolamide after corneal and scleral administration: The effect of ionization state

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    41. WANG RF; SCHUMER RA; SERLE JB; PODOS SM
      A COMPARISON OF ARGON-LASER AND DIODE-LASER PHOTOCOAGULATION OF THE TRABECULAR MESHWORK TO PRODUCE THE GLAUCOMA MONKEY MODEL

      Journal of glaucoma
    42. IYER GR; TAFT DR
      DETERMINATION OF METHAZOLAMIDE CONCENTRATIONS IN HUMAN BIOLOGICAL-FLUIDS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of pharmaceutical and biomedical analysis
    43. Zagrobelny, J; Matuszewski, BK; Kline, WF; Vincent, SH
      Separation of the four stereoisomers of a potent inhibitor (L-694,458) of human leukocyte elastase and its determination in human plasma using achiral/chiral chromatography with column switching

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    44. BRANDT C; GRUNZE H; NORMANN C; WALDEN J
      ACETAZOLAMIDE IN THE TREATMENT OF ACUTE MANIA - A CASE-REPORT

      Neuropsychobiology
    45. SUPURAN CT; CLARE BW
      CARBONIC-ANHYDRASE INHIBITORS - PART 47 - QUANTUM-CHEMICAL QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS FOR A GROUP OF SULFANILAMIDE SCHIFF-BASE INHIBITORS OF CARBONIC-ANHYDRASE

      European journal of medicinal chemistry
    46. Arici, MK; Topalkara, A; Guler, C
      Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure

      INTERNATIONAL OPHTHALMOLOGY
    47. VANLANDINGHAM BD; MAUS TL; BRUBAKER RF
      THE EFFECT OF DORZOLAMIDE ON AQUEOUS-HUMOR DYNAMICS IN NORMAL HUMAN-SUBJECTS DURING SLEEP

      Ophthalmology (Rochester, Minn.)
    48. EGAN CA; HODGE DO; MCLAREN JW; BOURNE WM
      EFFECT OF DORZOLAMIDE ON CORNEAL ENDOTHELIAL FUNCTION IN NORMAL HUMANEYES

      Investigative ophthalmology & visual science
    49. AALTOKORTE E
      CONTACT ALLERGY TO DORZOLAMIDE EYEDROPS

      Contact dermatitis
    50. LASS JH; KHOSROF SA; LAURENCE JK; HORWITZ B; GHOSH K; ADAMSONS I
      A DOUBLE-MASKED, RANDOMIZED, 1-YEAR STUDY COMPARING THE CORNEAL EFFECTS OF DORZOLAMIDE, TIMOLOL, AND BETAXOLOL

      Archives of ophthalmology
    51. STEWART WC; GARRISON PM
      BETA-BLOCKER-INDUCED COMPLICATIONS AND THE PATIENT WITH GLAUCOMA - NEWER TREATMENTS TO HELP REDUCE SYSTEMIC ADVERSE EVENTS

      Archives of internal medicine
    52. MANNI GL; CENTOFANTI M; NAPOLI D; PARISI V; BUCCI MG
      HYPOTENSIVE EFFECTS OF DORZOLAMIDE EYEWASH IN MAXIMAL THERAPY GLAUCOMA PATIENTS - A COMPARATIVE-STUDY WITH ORAL ACETAZOLAMIDE

      Acta ophthalmologica Scandinavica
    53. UVA MG; RUSSO V; LONGO A; OTT JP; REIBALDI A
      2-PERCENT DORZOLAMIDE AND CORNEA - AN ULTRABIOMICROSCOPIC STUDY

      Acta ophthalmologica Scandinavica
    54. CONROY CW
      SULFONAMIDES DO NOT REACH THE RETINA IN THERAPEUTIC AMOUNTS AFTER TOPICAL APPLICATION TO THE CORNEA

      Journal of ocular pharmacology and therapeutics
    55. ZAGROBELNY J; MATUSZEWSKI BK
      COLUMN-SWITCHING ACHIRAL CHIRAL SEPARATION OF THE STEREOISOMERS OF H,4H-1,2,4-TRIAZOLO)METHYL]-3-(S)-PHENYLMORPHOLINE IN PLASMA/

      Enantiomer
    56. ZAMBARAKJI HJ; SPENCER AF; VERNON SA
      AN UNUSUAL SIDE-EFFECT OF DORZOLAMIDE

      Eye
    57. SCHMIDT KG; DICK B; VONRUCKMANN A; PILLUNAT LE
      OCULAR PULSE AMPLITUDE AND DORZOLAMIDE

      Der Ophthalmologe
    58. CONSTANZER ML; CHAVEZ CM; MATUSZEWSKI BK
      LOW-LEVEL DETERMINATION OF DORZOLAMIDE AND ITS DE-ETHYLATED METABOLITE IN HUMAN PLASMA BY LIQUID-CHROMATOGRAPHY WITH ATMOSPHERIC-PRESSURE CHEMICAL-IONIZATION TANDEM MASS-SPECTROMETRY

      Journal of pharmaceutical and biomedical analysis
    59. LOFTSSON T; STEFANSSON E
      EFFECT OF CYCLODEXTRINS ON TOPICAL DRUG-DELIVERY TO THE EYE

      Drug development and industrial pharmacy
    60. GROVER S; FISHMAN GA; FISCELLA RG; ADELMAN AE
      EFFICACY OF DORZOLAMIDE HYDROCHLORIDE IN THE MANAGEMENT OF CHRONIC CYSTOID MACULAR EDEMA IN PATIENTS WITH RETINITIS-PIGMENTOSA

      Retina
    61. RULO AH; GREVE EL; HOYNG PFJ
      ADDITIVE OCULAR HYPOTENSIVE EFFECT OF LATANOPROST AND ACETAZOLAMIDE -A SHORT-TERM STUDY IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE

      Ophthalmology
    62. HEIJL A; STRAHLMAN E; SVERRISSON T; BRINCHMANHANSEN O; PUUSTJARVI T; TIPPING R
      A COMPARISON OF DORZOLAMIDE AND TIMOLOL IN PATIENTS WITH PSEUDOEXFOLIATION AND GLAUCOMA OR OCULAR HYPERTENSION

      Ophthalmology
    63. WU QA; DELAMERE NA; PIERCE W
      MEMBRANE-ASSOCIATED CARBONIC-ANHYDRASE IN CULTURED RABBIT NONPIGMENTED CILIARY EPITHELIUM

      Investigative ophthalmology & visual science
    64. PRUEKSARITANONT T; GORHAM LM; NAUE JA; HAMILL TG; ASKEW BC; VYAS KP
      DISPOSITION OF L-738,167, A POTENT AND LONG-ACTING FIBRINOGEN RECEPTOR ANTAGONIST, IN DOGS - DOSE-DEPENDENT PHARMACOKINETICS

      Drug metabolism and disposition
    65. PFEIFFER N
      DORZOLAMIDE - DEVELOPMENT AND CLINICAL-APPLICATION OF A TOPICAL CARBONIC-ANHYDRASE INHIBITOR

      Survey of ophthalmology
    66. LIN JH; LU AYH
      ROLE OF PHARMACOKINETICS AND METABOLISM IN DRUG DISCOVERY AND DEVELOPMENT

      Pharmacological reviews
    67. HINDERLING PH
      RED-BLOOD-CELLS - A NEGLECTED COMPARTMENT IN PHARMACOKINETICS AND PHARMACODYNAMICS

      Pharmacological reviews
    68. DENK PO; KNORR M; KRIEGEROWSKI M; THIEL HJ
      VALUE OF DORZOLAMID AS AN ADJUNCT TO MAXI MUM TOLERATED MEDICAL THERAPY

      Klinische Monatsblatter fur Augenheilkunde
    69. SUGRUE MF
      NEW APPROACHES TO ANTIGLAUCOMA THERAPY

      Journal of medicinal chemistry
    70. MAREN TH
      SULFONAMIDES AND SECRETION OF AQUEOUS-HUMOR

      The Journal of experimental zoology
    71. LADAS ID; BALTATZIS S; PANAGIOTIDIS D; ZAFIRAKIS P; KOKOLAKIS SN; THEODOSSIADIS GP
      TOPICAL 2.0-PERCENT DORZOLAMIDE VS ORAL ACETAZOLAMIDE FOR PREVENTION OF INTRAOCULAR-PRESSURE RISE AFTER NEODYMIUM-YAG LASER POSTERIOR CAPSULOTOMY

      Archives of ophthalmology
    72. HARRIS A; TIPPKE S; SIEVERS C; PICHT G; LIEB W; MARTIN B
      ACETAZOLAMIDE AND CO2 - ACUTE EFFECTS ON CEREBRAL AND RETROBULBAR HEMODYNAMICS

      Journal of glaucoma
    73. PERCICOT CL; SCHNELL CR; DEBON C; HARITON C
      CONTINUOUS INTRAOCULAR-PRESSURE MEASUREMENT BY TELEMETRY IN ALPHA-CHYMOTRYPSIN-INDUCED GLAUCOMA MODEL IN THE RABBIT - EFFECTS OF TIMOLOL, DORZOLAMIDE, AND EPINEPHRINE

      Journal of pharmacological and toxicological methods
    74. SIMPSON AJ; GRAY TB; BALLANTYNE C
      A CONTROLLED CLINICAL-TRIAL OF DORZOLAMIDE - A SINGLE-CENTER SUBSET OF A MULTICENTER STUDY

      Australian and New Zealand journal of ophthalmology
    75. PRADHAN S; WU AT; LESKO LJ; CHEN ML; WILLIAMS RL
      BIOAVAILABILITY MEASUREMENTS OF METHAZOLAMIDE IN PLASMA, RED-BLOOD-CELLS AND WHOLE-BLOOD - IMPLICATIONS FOR BIOEQUIVALENCE STUDIES

      International journal of pharmaceutics
    76. CHOW K; LAI R; HOLMES JM; WIJONO M; WHEELER LA; GARST ME
      5-SUBSTITUTED 3-THIOPHENESULFONAMIDES AS CARBONIC-ANHYDRASE INHIBITORS

      European journal of medicinal chemistry
    77. STRAHLMAN ER; VOGEL R; TIPPING R; CLINESCHMIDT CM; LEWIS R; KEATES E; QUIGLEY H; ZIMMERMAN T; ABELSON MB; ALLEN RC; BROWN RH; CACIOPPO LR; CYRLIN MN; GIESER DK; GREENIDGE KC; GROSS RL; KARP DW; KOBY MM; KASS M; LAIBOVITZ R; MCMAHON CD; OSTROV CS; WALTERS T; RITCH R; SAMPLES JR; SCHUMAN SJ; SERLE J; VELATHOMAS MA; BOYLE J; LIPPA E; REINES S; STRAHLMAN E; STROHMAIER K
      THE USE OF DORZOLAMIDE AND PILOCARPINE AS ADJUNCTIVE THERAPY TO TIMOLOL IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE

      Ophthalmology
    78. LORRAINE K; KING S; GREASHAM R; CHARTRAIN M
      ASYMMETRIC BIOREDUCTION OF A KETOSULFONE TO THE CORRESPONDING TRANS-HYDROXYSULFONE BY THE YEAST RHODOTORULA-RUBRA MY-2169

      Enzyme and microbial technology
    79. WONG BK; BRUHIN PJ; BARRISH A; LIN JH
      NONLINEAR DORZOLAMIDE PHARMACOKINETICS IN RATS - CONCENTRATION-DEPENDENT ERYTHROCYTE DISTRIBUTION AND DRUG-METABOLITE DISPLACEMENT INTERACTION

      Drug metabolism and disposition
    80. LEE SH; LEE MG
      STABILITY, TISSUE METABOLISM, TISSUE DISTRIBUTION AND BLOOD PARTITIONOF AZOSEMIDE

      Biopharmaceutics & drug disposition
    81. LIN JH
      SPECIES SIMILARITIES AND DIFFERENCES IN PHARMACOKINETICS

      Drug metabolism and disposition
    82. PEDREGOSA JC; CASANOVA J; ALZUET G; BORRAS J; GARCIAGRANDA S; DIAZ MR; GUTIERREZRODRIGUEZ A
      METAL-COMPLEXES OF YLOXYCARBONYLAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE(B-H(2)ATS), A CARBONIC-ANHYDRASE INHIBITOR - SYNTHESIS AND CHARACTERIZATION OF THE COPPER(II) COMPLEX - CRYSTAL-STRUCTURES OF B-H(2)ATS AND THE [CU(B-ATS)(NH3)(2)](2) DIMER COMPLEX

      Inorganica Chimica Acta
    83. WANG RF; PODOS SM
      EFFECT OF THE TOPICAL APPLICATION OF NITROGLYCERIN ON INTRAOCULAR-PRESSURE IN NORMAL AND GLAUCOMATOUS MONKEYS

      Experimental Eye Research
    84. STRAHLMAN E; TIPPING R; VOGEL R
      A DOUBLE-MASKED, RANDOMIZED 1-YEAR STUDY COMPARING DORZOLAMIDE (TRUSOPT), TIMOLOL, AND BETAXOLOL

      Archives of ophthalmology
    85. SERLE JB
      PHARMACOLOGICAL ADVANCES IN THE TREATMENT OF GLAUCOMA

      Drugs & aging
    86. LIN JH
      DOSE-DEPENDENT PHARMACOKINETICS - EXPERIMENTAL-OBSERVATIONS AND THEORETICAL CONSIDERATIONS

      Biopharmaceutics & drug disposition
    87. HASEGAWA T; HARA K; HATA S
      BINDING OF DORZOLAMIDE AND ITS METABOLITE, N-DEETHYLATED DORZOLAMIDE,TO HUMAN ERYTHROCYTES IN-VITRO

      Drug metabolism and disposition
    88. WONG PSK; BARCLAY PL; NEWMAN MJ; JOHNS EJ
      THE INFLUENCE OF ACETAZOLAMIDE AND AMLODIPINE ON THE INTRACELLULAR SODIUM CONTENT OF RAT PROXIMAL TUBULAR CELLS

      British Journal of Pharmacology
    89. LIN JH; LIN TH; CHENG HY
      UPTAKE AND STEREOSELECTIVE BINDING OF THE ENANTIOMERS OF MK-927, A POTENT CARBONIC-ANHYDRASE INHIBITOR, BY HUMAN ERYTHROCYTES INVITRO

      Pharmaceutical research
    90. TEMEL A; KAZOKOGLU H
      EFFECT OF THE APPLICATION OF ACETAZOLAMIDE SOAKED CONTACT-LENSES ON INTRAOCULAR-PRESSURE OF RABBITS

      Documenta ophthalmologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 07:06:22